Market revenue in 2023 | USD 2,904.1 million |
Market revenue in 2030 | USD 6,153.2 million |
Growth rate | 11.3% (CAGR from 2023 to 2030) |
Largest segment | Therapeutics |
Fastest growing segment | Diagnostics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostics, Therapeutics |
Key market players worldwide | Roche, Siemens Healthineers AG ADR, Janssen Pharmaceuticals, Illumina Inc, Quest Diagnostics Inc, 23andMe Holding Co Class A, NeoDiagnostix, International Business Machines Corp, Myriad Genetics Inc, Medtronic PLC, GE HealthCare Technologies Inc Common Stock, Abbott Laboratories, Dakota Software, Biogen Inc, Qiagen NV, ImmunityBio Inc Ordinary Shares |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision medicine market will help companies and investors design strategic landscapes.
Therapeutics was the largest segment with a revenue share of 74.18% in 2023. Horizon Databook has segmented the Latin America precision medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
The paradigm of genomic medicine has made significant advances, and personalized/precision medicine is now emerging prominently. Mexico and other Latin American countries have begun to establish their personalized medicine frameworks based on regional genetic/genomic characteristics.
However, despite these initial efforts, Latin America as a whole still lags in creating a new health paradigm centered on personalized medicine, and there is a shortage of medical specialists and researchers trained in this field.
Profound changes are required at the national level to revise medical curricula and healthcare systems to enable all Latin American countries to achieve this goal. A regional strategic plan based on collaboration and networking among academic and research universities, medical associations, public & private healthcare institutions, industries, and governments is essential to build national personalized-medicine models.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America precision medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America precision medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account